RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.1%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.62B
AUM Growth
+$1.62B
(+5.1%)
Cap. Flow
-$63.6M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
74
New
14
Increased
22
Reduced
20
Closed
12
Top Buys
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$66.3M |
| 2 |
Centene
CNC
|
$31.8M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$27.9M |
| 4 |
Edwards Lifesciences
EW
|
$25.8M |
| 5 |
iRhythm Technologies
IRTC
|
$20.2M |
Top Sells
| 1 |
Puma Biotechnology
PBYI
|
$75.6M |
| 2 |
Incyte
INCY
|
$41.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$28.3M |
| 4 |
Molina Healthcare
MOH
|
$22.2M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$21.9M |
Sector Composition
| 1 | Healthcare | 89.8% |
| 2 | Financials | 1.42% |
| 3 | Communication Services | 0.7% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNC
26
DELISTED
Spectranetics Corp
SPNC
| $24.4M | 1.48% |
634,802
+77,613
| +14% | +$2.98M |
|
27
eHealth
EHTH
$126M
| $23M | 1.4% |
1,223,334
+32,000
| +3% | +$602K |
|
|
CMRX
28
DELISTED
Chimerix, Inc.
CMRX
| $22.9M | 1.4% |
4,207,575
-117,480
| -3% | -$640K |
|
29
ICU Medical
ICUI
$3.06B
| $22.9M | 1.39% |
132,505
-28,038
| -17% | -$4.84M |
|
|
LJPC
30
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $21.2M | 1.29% |
713,280
+108,810
| +18% | +$3.24M |
|
|
31
iRhythm Technologies
IRTC
$5.67B
| $20.2M | 1.23% |
+476,341
| New | +$20.2M |
|
|
BPMC
32
DELISTED
Blueprint Medicines
BPMC
| $18.6M | 1.13% |
367,537
-32,463
| -8% | -$1.64M |
|
33
Vertex Pharmaceuticals
VRTX
$102B
| $18.6M | 1.13% |
+144,408
| New | +$18.6M |
|
|
GBT
34
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.3M | 1.05% |
631,283
-303,060
| -32% | -$8.29M |
|
|
NDRM
35
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $16.6M | 1.01% |
555,096
-369,208
| -40% | -$11M |
|
|
NXTM
36
DELISTED
NxStage Medical Inc.
NXTM
| $16.5M | 1% |
+657,356
| New | +$16.5M |
|
|
JNCE
37
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $16M | 0.97% |
1,138,370
+24,210
| +2% | +$340K |
|
|
SYRS
38
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $15.7M | 0.95% |
973,260
+20,520
| +2% | +$330K |
|
|
NSTG
39
DELISTED
NanoString Technologies, Inc.
NSTG
| $14.3M | 0.87% |
866,819
-67,605
| -7% | -$1.12M |
|
|
CASC
40
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $13.9M | 0.84% |
3,735,994
-336,430
| -8% | -$1.25M |
|
41
LivaNova
LIVN
$3.09B
| $13M | 0.79% |
+212,028
| New | +$13M |
|
|
MODN
42
DELISTED
MODEL N, INC.
MODN
| $11.4M | 0.69% |
858,314
+36,000
| +4% | +$479K |
|
43
CytomX Therapeutics
CTMX
$350M
| $10.8M | 0.66% |
698,392
+16,500
| +2% | +$256K |
|
44
ProQR Therapeutics
PRQR
$256M
| $8.3M | 0.51% |
1,596,275
+43,050
| +3% | +$224K |
|
|
NVTA
45
DELISTED
Invitae Corporation
NVTA
| $7.77M | 0.47% |
812,240
| – | – |
|
|
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $6.69M | 0.41% |
+599,620
| New | +$6.69M |
|
47
Medpace
MEDP
$13.5B
| $6.53M | 0.4% |
+225,040
| New | +$6.53M |
|
|
CTLT
48
DELISTED
CATALENT, INC.
CTLT
| $5.12M | 0.31% |
145,963
-478,037
| -77% | -$16.8M |
|
49
Fate Therapeutics
FATE
$115M
| $4.6M | 0.28% |
1,419,058
| – | – |
|
50
Ovid Therapeutics
OVID
$94.6M
| $4.24M | 0.26% |
+448,781
| New | +$4.24M |
|